Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models.
about
Multiple Aspects of Gene Dysregulation in Huntington's DiseaseCocaine alters BDNF expression and neuronal migration in the embryonic mouse forebrainThe HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.Targeting New Candidate Genes by Small Molecules Approaching Neurodegenerative DiseasesNucleolar dysfunction in Huntington's diseaseEpigenetic Regulation of Immunological Alterations Following Prenatal Exposure to Marijuana Cannabinoids and its Long Term Consequences in OffspringMouse models of polyglutamine diseases in therapeutic approaches: review and data table. Part II.Epigenetic Changes in Neurodegenerative DiseasesMolecular mechanisms of synaptic remodeling in alcoholismThe promise and perils of HDAC inhibitors in neurodegenerationEpigenetic mechanisms of neurodegeneration in Huntington's diseaseOral administration of the pimelic diphenylamide HDAC inhibitor HDACi 4b is unsuitable for chronic inhibition of HDAC activity in the CNS in vivoFunctional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's diseaseAlterations in brain-derived neurotrophic factor in the mouse hippocampus following acute but not repeated benzodiazepine treatmentGenome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's diseaseGenetic knock-down of HDAC3 does not modify disease-related phenotypes in a mouse model of Huntington's diseaseMultiple phenotypes in Huntington disease mouse neural stem cells.Histone acetylation, acetyltransferases, and ataxia--alteration of histone acetylation and chromatin dynamics is implicated in the pathogenesis of polyglutamine-expansion disordersEpigenetic inheritance of a cocaine-resistance phenotype.Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6/2 mouse model of Huntington's diseaseAge-associated chromatin relaxation is enhanced in Huntington's disease mice.Pharmacology of epigenetics in brain disordersHistone modifications are associated with Δ9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responsesThe polyubiquitin Ubc gene modulates histone H2A monoubiquitylation in the R6/2 mouse model of Huntington's disease.Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine.Epigenetic memory: the Lamarckian brainGenome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease.Histone methylation and acetylation indicates epigenetic change in the aged cochlea of mice.MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanismsTranscription, epigenetics and ameliorative strategies in Huntington's Disease: a genome-wide perspectiveHuntington's Disease and Striatal Signaling.Transcriptional modulator H2A histone family, member Y (H2AFY) marks Huntington disease activity in man and mouseThe Role of H3K4me3 in Transcriptional Regulation Is Altered in Huntington's DiseasePolyglutamine (polyQ) disorders: the chromatin connection.Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease.Poly-glutamine expanded huntingtin dramatically alters the genome wide binding of HSF1.Extensive changes in DNA methylation are associated with expression of mutant huntingtin.CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.Epigenetics in nucleotide repeat expansion disorders.DNA methylation in Huntington's disease: Implications for transgenerational effects
P2860
Q24605880-F63A5147-9DEA-43E8-8EE2-8F2E80DE620CQ24635363-90B0B1D3-3F74-4D19-A24F-44C6A38988C4Q24656405-C3C39D3E-3195-4D1B-B324-0DD14CC8D94BQ26771812-4D75F29F-4832-4942-BE82-9910F577632BQ26822451-F63644AA-8D96-4810-912D-806BBF8F45A2Q26864359-A287845E-48BC-4090-95D7-F17E6808C6F5Q27005950-602C4452-86C1-445A-8C8B-ADB814017ACBQ28075559-6C294B98-CD21-4CE5-BC75-8FE2812B1F25Q28080843-4112FAD7-33D9-4412-8C80-34F5DFD9D978Q28087539-8D64ECEB-14E0-402C-BD37-72518B5D53BFQ28297936-963FAC4E-27A6-4B75-BFCB-8C15B394576DQ28483335-E57C2514-FE1C-4F93-80C1-03F157E5BF8AQ28507781-29F0FC4B-1A2D-4DCB-8D6C-06EC37EB28FAQ28537823-F3FF9064-03E8-4980-94E8-3CC32E428759Q28594357-0E993B47-C9E6-46B8-BB8D-CA3362A29FE9Q28732195-D1FDFE3B-0E74-4A61-B58D-29FE09D8ACE5Q30419653-D6D5DAD2-A8A2-444C-9FEA-42018702DEDEQ30433574-6B2FF5FA-D32F-40DB-817D-2E85467BA74CQ30530759-C1C6A0AC-7BEB-49D3-87F2-0A080D23EB9DQ33457171-8E0733DE-CBE7-470E-9B19-E26E64DA5BB1Q33563614-F823914B-6886-4BDF-B6CB-FD1046395F58Q33673025-247EBB4C-1D1E-45DA-B837-3D84D8AEC629Q33846410-5EAEA60C-8FED-4526-B401-7D8C744F4195Q33942346-C3D9FF71-241D-45A5-8A52-9E98F9427102Q34145195-B3AC8043-6585-4CF2-BF76-46801F82B241Q34323841-38FA21B7-F63C-4B7B-ADAD-4B0E0AAAB3C9Q34358457-A97A6010-1733-437F-AEC8-0EE41351FF67Q34451733-00AED60F-A46F-403E-838D-56BF7224A964Q34562807-76B9B844-E6BF-41E2-82A9-330FB9CDD00AQ35024695-3BEAFFF9-F6A7-4475-886F-FFE89439F70DQ35286098-70784485-2B8F-447E-B01C-9C4E5A3C7A8FQ35345762-EFF2CD36-4C76-4BB7-9327-E56B956255FEQ35860836-9CA8E36C-4A06-4FBF-8433-9BEEF08F1DE7Q36328114-6034AF6A-5917-49F3-8150-8866D0CACB34Q36482299-68C2EB08-A23E-4750-8BF0-65D28F9D557DQ36509945-95B6EAC2-22EC-4541-BFC4-EAF05A744E95Q36598186-10A7EC10-6620-469D-B35E-463D7AAF9913Q36615488-7511F72F-55DF-4A8C-A232-6DA4A1A04DC5Q36848454-7066C792-FCE9-41E1-A993-861BE7E9AD3DQ36892975-81C9A178-8F03-49AB-A60F-43BFACD8E4A1
P2860
Histones associated with downregulated genes are hypo-acetylated in Huntington's disease models.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Histones associated with downr ...... n Huntington's disease models.
@en
Histones associated with downr ...... n Huntington's disease models.
@nl
type
label
Histones associated with downr ...... n Huntington's disease models.
@en
Histones associated with downr ...... n Huntington's disease models.
@nl
prefLabel
Histones associated with downr ...... n Huntington's disease models.
@en
Histones associated with downr ...... n Huntington's disease models.
@nl
P2093
P50
P356
P1476
Histones associated with downr ...... n Huntington's disease models.
@en
P2093
Caroline L Benn
George J Yohrling
Jang-Ho J Cha
Kelly E Glajch
Mee-Ohk Kim
Prianka Chawla
Ryan P Overland
Zhihua Qiu
P304
P356
10.1093/HMG/DDM078
P577
2007-04-04T00:00:00Z